“Smart investors know the biotech industry’s full of clinical-stage companies that can explode in value overnight in response to positive clinical trial results or Food and Drug Administration approvals,” notes […]
read more
3 Biotech Stocks To Watch As 2021 Gets Underway
When it comes to the biotech stocks that experienced strong growth in 2020, the author of today’s article notes that the “more obvious cases such as vaccine company Moderna have […]
read more
“The Best Biotech Stock On The Market” – And 2 Other Picks To Consider Buying Right Now
“I genuinely think that [this] is the best biotech stock on the market. The company is rolling in dough,” declares the author of today’s article in regards to one of […]
read more
Is This One-Dose mRNA COVID Vaccine Stock A Must-Buy?
Like the Pfizer and Moderna vaccines, the COVID-19 vaccine candidate being developed by the mid-cap biotech featured in today’s article uses a messenger RNA (mRNA) platform. Unlike the Pfizer and […]
read more
Significant Upside Potential (And Dividends) Make These 3 Biotech Stocks To Watch
“The best biotech companies offer a nice balance between several established drugs bringing the company consistent income along with a robust pipeline of potential blockbuster drugs. However, investing in emerging […]
read more
3 Stocks To Play Biotech’s Continued Outperformance In 2021
When it comes to biotech in 2021, the author of today’s article expects the sector to remain very attractive, noting that “Valuations are quite reasonable and earnings have steadily increased. […]
read more
New Biotech Stocks To Watch – And More!
Companies involved in biopharmaceuticals, medical devices and biotechnology medicines make up the nine new biotech stocks to watch highlighted in today’s article, which also highlights new stocks to watch in […]
read more
Strong Drug Pipelines (And Balance Sheets) May Make These The Best Biotech Stocks To Buy Right Now
“Smart investors will look for biotech stocks that have drug pipelines full of good prospects, as well as balance sheets strong enough to withstand any unforeseen problems,” acknowledges the author […]
read more
The Next Biotechs To Be Bought Up
When it comes to the question of which biotech companies could be the next M&A targets, one analyst cited in today’s article says the “easy answer” is oncology companies, as […]
read more
4 ‘Strong Buy’/‘Buy’ Biotech Stocks
The author of today’s article notes that, while the “upside in biotech sector has been led by positive developments at small companies, primarily the ones developing a vaccine or treatment […]
read more